Intercept to Present at Upcoming Investor Conferences in June
- Jefferies 2019 Healthcare Conference in
New York, NYat 9:00 a.m. ETon Thursday, June 6, 2019
- Goldman Sachs 40th Annual Global Healthcare Conference in
Rancho Palos Verdes, CAat 1:20 p.m. PTon Wednesday, June 12, 2019 Raymond James Life Sciences and MedTech Conferencein New York, NYat 10:55 a.m. ETon Tuesday, June 18, 2019
Webcast information for these events will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept’s website for approximately two weeks.
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in
For more information about Intercept, please contact:
Media inquiries: email@example.com
Source: Intercept Pharmaceuticals, Inc.